The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Cantourage introduces second Clever Leaves medical cannabis product to the German market
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Subscribe To Our Newsletter & Stay Updated
